Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

FHS
July 6, 2023
10:56 am

Researchers assessed acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC).

Researchers discover how gut microbes influence social behavior in mice

For people with autism, constipation, diarrhea, and abdominal pain often go along with the social struggles and repetitive behaviors that define the condition.

May 13, 2024

MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction – Biotech Investments

MorphoSys AG / Key word(s): Study results Ad hoc: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction

November 21, 2023

Takeda CEO Christophe Weber to step down following prolonged drop in company shares

Christophe Weber will step down as CEO of Takeda next year, the company announced Thursday, following a drop-off in its share price over the last

January 30, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.